Objective-Therapeutic angiogenesis aims at the promotion of vascular growth, usually under conditions of atherosclerosis.
M ajor efforts have been made in human patients with atherosclerosis to stimulate angiogenesis by delivery of vascular endothelial growth factor (VEGF) or of viral vectors or plasmids containing the VEGF transgene. [1] [2] [3] [4] Functionally relevant improvements were noticed only in some, [5] [6] [7] [8] [9] [10] but not other, [11] [12] [13] clinical studies, in which VEGF was delivered for the prevention of coronary heart or peripheral occlusive artery disease. Thus, the translation of therapeutic angiogenesis from bench to bedside still hampers.
Reflecting the deposition of lipids into vessel walls either because of dietary habits or genetic predisposition, atherosclerosis is frequently accompanied by lipid abnormalities. In ischemic stroke, about half of the patients exhibit hyperlipidemia, 1, 14 and subjects with hyperlipidemia in turn have an elevated stroke mortality. 10, 15 Chronically increased cholesterol levels trigger a number of vascular events, such as oxidative stress, endothelial dysfunction, blood-brain barrier disturbances, and vascular inflammation. [16] [17] [18] [19] Although the consequences of elevated cholesterol levels for vascular integrity are well established and spontaneous angiogenesis is compromised, 16, 20, 21 it is still unknown how hyperlipidemia influences angiogenesis in response to VEGF treatment. Because of severe hemodynamic abnormalities, patients with intracranial atherosclerosis, which is particularly strongly associated with dyslipidemia, 22, 23 might specifically be eligible for angiogenic therapies. Thus, the question how hyperlipidemic blood vessels respond to VEGF possesses high-clinical relevancy.
To elucidate effects of hyperlipidemia on VEGFinduced angiogenesis, we herein treated normolipidemic July 2013 or hyperlipidemic C57BL6 wild-type and apolipoprotein-E (ApoE) −/− mice by intracerebroventricular infusion with normal saline or VEGF for 21 days and exposed these animals to focal cerebral ischemia. We subsequently analyzed changes in brain capillary density, regional cerebral blood flow (CBF), cerebral protein synthesis and energy state, and histological brain injury.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

VEGF-Induced Capillary Formation Is Blunted by Hyperlipidemia
To examine how the delivery of VEGF influences microvascular networks in wild-type and ApoE −/− mice, brain capillary density was analyzed by CD31 immunohistochemistry.
VEGF delivered at a dose of 0.02 µg/day 24 increased capillary density in wild-type mice on regular, that is, normal diet and cholesterol-rich, that is, Western diet and ApoE −/− mice on normal diet but not in ApoE −/− mice on Western diet ( Figure  1A and 1B), which exhibit highest plasma cholesterol levels. 17 Three-way ANOVA showed a significant interaction effect for VEGF×ApoE×dietary status on capillary density (F 1,39 =4.444; P<0.05), demonstrating that angiogenesis was prevented by hyperlipidemia, most strongly in ApoE −/− mice on Western diet.
Hyperlipidemia Abolishes VEGF-Induced Neuroprotection and Blood-Brain Barrier Integrity
To evaluate the effects of hyperlipidemia on histopathologic brain injury and blood-brain barrier integrity, mice treated with vehicle or VEGF were exposed to 90-minute middle cerebral artery occlusion followed by 24 hours reperfusion. Laser Doppler flow recordings taken during and after middle cerebral artery occlusion revealed reproducible ischemia that did not differ between vehicle-and VEGF-treated mice (Figure 2A and 2B). Postischemic Laser Doppler flow values were lower in animals on Western diet than in animals on normal diet (Figure 2A Infarct measurements on cresyl violet stainings at 24 hours after reperfusion revealed that VEGF reduced infarct volume in the wild-type mice kept on normal diet ( Figure 3A ), which is in line with earlier results of our group, 25, 26 and in wild-type mice kept on Western diet ( Figure 3A ). Conversely, VEGF did not influence infarct size in ApoE −/− mice on normal diet or ApoE −/− mice on Western diet ( Figure 3B ). The attenuation of brain injury was associated with reduced immunoglobulin G extravasation in wild-type mice on normal diet, but not in any of the other groups ( Figure 3C and 3D).
Hyperlipidemia Prevents VEGF-Induced Extracellular Matrix Preservation
To assess how hyperlipidemia influences extracellular matrix integrity after VEGF treatment, matrix metalloproteinase-9 activity was analyzed by gelatin zymography. In line with a previous study, 24 VEGF reduced matrix metalloproteinase-9 activity both in ischemic tissue samples obtained from wildtype and ApoE −/− mice, yet more strongly in animals kept on normal diet than on Western diet ( Figure 3E and 3F), indicating that hyperlipidemia promoted extracellular matrix breakdown. Indeed, VEGF-treated ApoE −/− mice on Western diet exhibited significantly higher matrix metalloproteinase-9 activity than ApoE −/− mice on normal diet ( Figure 3F ).
Hyperlipidemia Attenuates VEGF-Induced Improvement of Regional CBF
To elucidate the effect of VEGF-induced angiogenesis on brain hemodynamics during a subsequent stroke, CBF autoradiograms were analyzed at 60 minutes after middle cerebral artery occlusion. Increased regional CBF was noted in the middle cerebral artery territory of VEGF-treated wild-type mice on normal diet but not in VEGF-treated ApoE −/− mice on Western diet ( Figure 4A ), indicating a lack of functional hemodynamic improvements in animals on hyperlipidemia. Two-way ANOVA demonstrated a significant effect of VEGF (F 1,20 =8705; P<0.01), but no interaction effect with ApoE/ dietary status on regional CBF.
Hyperlipidemia Abolishes VEGF-Induced Stabilization of Metabolic Penumbra
To evaluate how the improvement of regional CBF influences regional cerebral energy state, cerebral protein synthesis and ATP bioluminescence images were assessed. A stabilization of the metabolic penumbra, defined as brain tissue in which cerebral protein synthesis was suppressed but ATP preserved, was noticed in VEGF-treated wild-type mice on normal diet but not in ApoE −/− mice on Western diet ( Figure 4B ). Two-way ANOVA showed a significant VEGF×ApoE/dietary status interaction effect (F 1,14 =4.663; P<0.05), indicating that hyperlipidemia promotes secondary brain infarction. Indeed, the tissue area exhibiting ATP depletion after 60 minutes of reperfusion was considerably smaller in normolipidemic wild-type than hyperlipidemic ApoE −/− mice ( Figure 4C ), although this difference still failed to show significance at this time point.
Hyperlipidemia Prevents VEGF-Induced Pericyte Alignment on Brain Capillaries
To examine the functionality of cerebral blood vessels in addition to structural growth, pericyte coverage was analyzed in brain tissue samples submitted to focal cerebral ischemia. In the ischemic tissue, the percentage of cerebral microvessels surrounded by pericytes was ≈60% in 20-µm-thick cryostat sections ( Figure 5A and 5B) . Interestingly, VEGF treatment increased the percentage of pericyte+ capillaries in wild-type mice on normal diet (relatively by ≈30%), but not in wild-type mice on Western diet or ApoE −/− mice on normal or Western diet ( Figure 5A and 5B) . Three-way ANOVA revealed a significant VEGF×ApoE×dietary status interaction effect (F 1,41 =4.487; P<0.05).
To further corroborate these findings, we subsequently performed a confocal data analysis, in which pericyte volumes determined in 3D stacks were related to volumes of CD31 + cerebral capillaries. This study again revealed an increased Figure 4 . Hyperlipidemia abolishes vascular endothelial growth factor (VEGF)-induced improvement of cerebral blood flow, promoting secondary breakdown of brain energy state. A, Regional cerebral blood flow (CBF) autoradiography showing increased blood flow values in ischemic brain tissue of VEGF-treated wild-type mice on normal diet that are attenuated in ApoE −/− mice on Western diet that exhibit hyperlipidemia. B, Metabolic penumbra, defined as tissue area in which cerebral protein synthesis is suppressed, but ATP preserved, exhibiting the viability of the metabolic penumbra as a result of the enhanced blood flow in VEGF-treated wild-type mice on normal diet, but not in hyperlipidemic ApoE −/− mice on Western diet. C, Tissue area exhibiting ATP depletion, revealing reduced breakdown of the cerebral energy state in VEGF-treated normolipidemic wild-type mice, but not in hyperlipidemic ApoE −/− mice. Animals were exposed to 90-minute middle cerebral artery occlusion, followed by 60 minutes reperfusion. Tissue samples derived from the ischemic middle cerebral artery territory (striatum and overlying cortex) were evaluated. Representative autoradiographies and bioluminescence images are also shown. For wild-type/ normal diet animals, see also reference 26 . Data are mean±SD (n=6 animals/group). *P<0.05/**P<0.01 compared with corresponding vehicle. CPS indicates cerebral protein synthesis.
pericyte coverage of brain endothelial cells in VEGF-treated wild-type mice on normal diet, but not in wild-type mice on Western diet or any of the ApoE −/− mice ( Figure 5C and 5D ). Three-way ANOVA again confirmed a VEGF×ApoE×dietary status interaction effect (F 1,41 =7325; P<0.05), confirming that hyperlipidemia disturbed the alignment of pericytes with endothelial cells.
Hyperlipidemia Attenuates N-Cadherin Expression in Cerebral Microvessels
The physical interaction of pericytes with endothelial cells is mediated by the junctional protein N-cadherin. 27 To evaluate whether N-cadherin expression was altered by blood lipids, Western blots were prepared with capillary extracts obtained from normolipidemic and hyperlipidemic wild-type Figure 5 . Hyperlipidemia prevents vascular endothelial growth factor (VEGF)-induced pericyte alignment on brain capillaries, preventing N-cadherin expression. A and B, Percentage of cerebral microvessels surrounded by pericytes in 20-µm-thick cryostat sections, (C and D) volume ratio of pericyte coverage of ischemic brain capillaries determined in 3D stacks, and (E and F) N-cadherin expression in ischemic cerebral microvessels of wild-type and ApoE −/− mice on normal or Western diet. Note the increased pericyte coverage in VEGFtreated wild-type mice on normal diet, but not in wild-type mice on Western diet or in ApoE −/− mice on normal or Western diet that exhibit hyperlipidemia (A-D). Also note the increased expression of N-cadherin, which physically links the pericytes with endothelial cells, in VEGF-treated wild-type mice on normal diet, but not in hyperlipidemic wild-type mice on Western diet or ApoE −/− mice. Animals were submitted to 90-minute middle cerebral artery occlusion followed by 24 hours reperfusion. Tissue samples derived from the ischemic middle cerebral artery territory (striatum and overlying cortex) were evaluated. Representative microphotographs or blots are also shown (A and B: CD31 in green/desmin in red). Data are mean±SD (n=6-7 animals/group [in A-E]/n=4 independently processed blots [in E and F]). *P<0.05/**P<0.01 compared with vehicle. Bar (A and B) , 100 µm. and ApoE −/− mice. This study revealed that VEGF potently increased N-cadherin levels in ischemic microvessels obtained from wild-type mice on normal diet, but not in any of the hyperlipidemic groups ( Figure 5E and 5F ). The lack of N-cadherin expression provides a mechanism for the disturbed pericyte coverage of endothelial cells in hyperlipidemia.
Discussion
Using a multiparametric approach combining histochemical, autoradiographic, bioluminescence, and molecular biological studies in vivo, we herein show that VEGF-induced angiogenesis is compromised by hyperlipidemia, translating into the loss of hemodynamic improvements after subsequent stroke injury, the breakdown of the metabolic penumbra, and brain infarction. N-cadherin expression was reduced on cerebral microvascular cells exposed to hyperlipidemia that was associated with decreased coverage of endothelial cells with pericytes, demonstrating that blood vessels were dysfunctional. In this study, wild-type and ApoE −/− mice fed with regular or cholesterol-rich chow were used to induce different degrees of hyperlipidemia. Our data might provide an explanation for the poor effects of angiogenic therapies in human patients with symptomatic atherosclerosis. [2] [3] [4] These patients frequently suffer from hyperlipidemia and particularly brain vessels are affected by atherosclerotic plaques. 22, 23 That VEGF induces brain angiogenesis is well established, whereas evidence for the hemodynamic relevance of these effects is less clear. 2 In an MRI study, acute VEGF infusion was previously shown to induce transient CBF increases in ischemic brain tissue lasting up to 3 hours, 28 which however was a consequence of VEGF-induced vasorelaxation rather than of induced vascular growth. In mice expressing human VEGF chronically in the whole brain under a neuron-specific enolase promoter, regional CBF was observed to be reduced in ischemic brain areas as a consequence of a hemodynamic steal flow. 25 The exogenous delivery of VEGF differs from transgenic VEGF expression, because it increases regional CBF in ischemic brain tissue. 26 Importantly, both the VEGFinduced angiogenesis and the enhancement of blood flow were blunted in animals exhibiting hyperlipidemia.
Impaired spontaneous angiogenesis has previously been noted under conditions of hyperlipidemia. 16, 20, 21 Thus, reduced vessel densities have been reported in hyperlipidemic rats exposed to hindlimb ischemia, which was attributed to reduced NO activity in hyperlipidemic ischemic tissue. 16 Consequences of hyperlipidemia on brain angiogenesis and on the responses of blood vessels to VEGF were so far unknown. In vitro studies reported that endothelial proliferation and migration, 2 fundamental processes required for angiogenesis, are impaired by oxidized low-density lipoprotein via mechanisms that involved reduced basic fibroblast growth factor expression 29, 30 and reduced endothelial NO synthase/Akt activity. 31 How VEGF signaling is altered in hyperlipidemic microvessels remains to be shown.
Besides preventing the sprouting of cerebral microvessels, hyperlipidemia abolished the enhanced coverage of endothelial cells with pericytes. Pericytes exert an important regulatory role in brain microvessels, inducing the formation of blood-brain barrier properties and controlling vascular reactivity. 27 Indeed, the preservation of blood-brain barrier integrity of the VEGF was abolished under conditions of hyperlipidemia, which was reflected by the enhanced access of serum IgG to the brain parenchyma, while matrix metalloproteinase-9 activity at the same time was increased. In line with the disturbed pericyte coverage, the junctional protein N-cadherin, which mediates physical interactions between endothelial cells and pericytes and which was upregulated by VEGF in normolipidemic microvessels, did not respond to VEGF in hyperlipidemic mice. That hyperlipidemia prevents the pericyte alignment with endothelial cells is noteworthy. It provides a new, hitherto unknown mechanism for disturbances of vascular reactivity in hyperlipidemia.
Translational stroke studies should be aware that hyperlipidemia alters responses of cerebral blood vessels to angiogenic growth factors. The lack of vascular growth responses after VEGF treatment questions the concept of therapeutic angiogenesis in ischemic stroke under conditions of hyperlipidemia.
By using wild-type and apolipoprotein-E (ApoE) −/− mice that were kept on regular or cholesterol-rich diet, we show that vascular endothelial growth factor-induced angiogenesis is attenuated in the brains of hyperlipidemic mice, whereas pericyte coverage of brain endothelial cells is impaired, resulting in the lack of cerebral blood flow improvement during subsequent middle cerebral artery occlusion, followed by the loss of the metabolic penumbra, which is defined as tissue at risk that is still amenable to therapeutic interventions, and secondary brain infarction. The compromised new vessel formation and disturbed cerebral hemodynamics question the concept of therapeutic angiogenesis in ischemic stroke, where hyperlipidemia is highly prevalent.
Significance
